AVTR - Avantor, Inc.
NYSE
->
Basic Materials
->
Specialty Chemicals
Radnor,
United States
Type: Equity
AVTR price evolution
AVTR
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $272.6 | $234.9 | $262.9 | |
| Short term investments | ||||
| Net receivables | $1087.7 | $1129 | $1129.7 | $1150.2 |
| Inventory | $779.6 | $795.6 | $810.6 | $828.1 |
| Total current assets | $2504.7 | $2329.2 | $2321.1 | $2384.9 |
| Long term investments | ||||
| Property, plant & equipment | $722.8 | $753.8 | $739.7 | $737.5 |
| Goodwill & intangible assets | $9242.4 | $9334.9 | $9492 | |
| Total noncurrent assets | $10364.3 | $10442.3 | $10587.8 | |
| Total investments | ||||
| Total assets | $12840.6 | $12693.5 | $12763.4 | $12972.7 |
| Current liabilities | ||||
| Accounts payable | $673.5 | $657.4 | $573.4 | $625.9 |
| Deferred revenue | ||||
| Short long term debt | $258.4 | $299.1 | $259.9 | |
| Total current liabilities | $1629.8 | $1464.6 | $1441.9 | $1480.3 |
| Long term debt | $4691.4 | $4856.6 | $5023.9 | $5276.7 |
| Total noncurrent liabilities | $5793.9 | $5985.2 | $6239.8 | |
| Total debt | $5115 | $5323 | $5536.6 | |
| Total liabilities | $7287.4 | $7258.5 | $7427.1 | $7720.1 |
| Shareholders' equity | ||||
| Retained earnings | $1702.6 | $1644.8 | $1551.9 | $1491.5 |
| Other shareholder equity | -$73.9 | -$107.3 | -$97 | -$69 |
| Total shareholder equity | $5435 | $5336.3 | $5252.6 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $262.9 | $372.9 | $301.7 | $286.6 |
| Short term investments | ||||
| Net receivables | $1150.2 | $1218.4 | $1222.1 | $1113.3 |
| Inventory | $828.1 | $913.5 | $872 | $739.6 |
| Total current assets | $2384.9 | $2657.9 | $2477.2 | $2230.9 |
| Long term investments | ||||
| Property, plant & equipment | $737.5 | $845.7 | $705.5 | $549.9 |
| Goodwill & intangible assets | $9492 | $9785.9 | $10481.4 | $6909 |
| Total noncurrent assets | $10587.8 | $10806.4 | $11420 | $7675.6 |
| Total investments | ||||
| Total assets | $12972.7 | $13464.3 | $13897.2 | $9906.5 |
| Current liabilities | ||||
| Accounts payable | $625.9 | $758.2 | $755.1 | $678.9 |
| Deferred revenue | ||||
| Short long term debt | $259.9 | $364.2 | $45.2 | $26.4 |
| Total current liabilities | $1480.3 | $1658.8 | $1450.8 | $1242.7 |
| Long term debt | $5276.7 | $5923.3 | $6978 | $4867.5 |
| Total noncurrent liabilities | $6239.8 | $6950.1 | $8249.4 | $5989.5 |
| Total debt | $5536.6 | $6287.5 | $7023.2 | $4893.9 |
| Total liabilities | $7720.1 | $8608.9 | $9700.2 | $7232.2 |
| Shareholders' equity | ||||
| Retained earnings | $1491.5 | $1170.4 | $483.9 | -$88.7 |
| Other shareholder equity | -$69 | -$100.3 | -$43.2 | $21.7 |
| Total shareholder equity | $5252.6 | $4855.4 | $4197 | $2674.3 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1714.4 | $1702.8 | $1679.8 | $1722.8 |
| Cost of revenue | $1121.3 | $1109.3 | $1152.4 | |
| Gross Profit | $564.4 | $581.5 | $570.5 | $570.4 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $405.7 | $424.2 | $387.1 | |
| Total operating expenses | $439.8 | $405.7 | $424.2 | $387.1 |
| Operating income | $175.8 | $146.3 | $183.3 | |
| Income from continuing operations | ||||
| EBIT | $175.5 | $144.9 | $184.8 | |
| Income tax expense | $16.7 | $21.7 | $20.2 | $21 |
| Interest expense | -$48.7 | $60.9 | $64.3 | $65.3 |
| Net income | ||||
| Net income | $57.8 | $92.9 | $60.4 | $98.5 |
| Income (for common shares) | $92.9 | $60.4 | $98.5 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $6967.2 | $7512.4 | $7386.1 | $6393.6 |
| Cost of revenue | $4603.4 | $4909.6 | $4883.4 | $4313.1 |
| Gross Profit | $2363.8 | $2602.8 | $2502.7 | $2080.5 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1506.6 | $1472.6 | $1530.5 | $1373.7 |
| Total operating expenses | $1667.4 | $1472.6 | $1530.5 | $1373.7 |
| Operating income | $696.4 | $1130.2 | $972.2 | $706.8 |
| Income from continuing operations | ||||
| EBIT | $695.3 | $1116.9 | $970.4 | $369.9 |
| Income tax expense | $89.4 | $164.6 | $180.4 | -$54.3 |
| Interest expense | $284.8 | $265.8 | $217.4 | $307.6 |
| Net income | ||||
| Net income | $321.1 | $686.5 | $572.6 | $116.6 |
| Income (for common shares) | $321.1 | $662.3 | $508 | $52 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $92.9 | $60.4 | $98.5 | |
| Operating activities | ||||
| Depreciation | $102.6 | $99.6 | $100.6 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $11.1 | $12.7 | $8.8 | |
| Total cash flows from operations | $281.1 | $141.6 | $251.6 | |
| Investing activities | ||||
| Capital expenditures | -$45.8 | -$34.7 | -$50.6 | |
| Investments | ||||
| Total cash flows from investing | -$119.6 | -$44.9 | -$34.2 | -$50 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $4.5 | $38.9 | $4 | |
| Net borrowings | -$201.6 | -$169.1 | -$188.1 | |
| Total cash flows from financing | -$525.9 | -$197.1 | -$130.2 | -$184.1 |
| Effect of exchange rate | $0.6 | -$1.6 | -$5.7 | $9.5 |
| Change in cash and equivalents | $22.6 | $37.5 | -$28.5 | $27 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $321.1 | $686.5 | $572.6 | $116.6 |
| Operating activities | ||||
| Depreciation | $402.3 | $405.5 | $379.2 | $395.4 |
| Business acquisitions & disposals | -$20.2 | -$4014.1 | ||
| Stock-based compensation | $40.5 | $45.8 | $50.7 | $44.1 |
| Total cash flows from operations | $870 | $843.6 | $953.6 | $929.8 |
| Investing activities | ||||
| Capital expenditures | -$146.4 | -$133.4 | -$111.1 | -$61.6 |
| Investments | ||||
| Total cash flows from investing | -$143.7 | -$109.6 | -$4121.7 | -$59.1 |
| Financing activities | ||||
| Dividends paid | -$64.6 | |||
| Sale and purchase of stock | $4.6 | $4.1 | $1023.7 | $20.2 |
| Net borrowings | -$848.3 | -$620.4 | $2260.1 | -$738.5 |
| Total cash flows from financing | -$843.7 | -$648.7 | $3219.2 | -$782.9 |
| Effect of exchange rate | $8.2 | -$15.5 | -$13.2 | $12.1 |
| Change in cash and equivalents | -$109.2 | $69.8 | $37.9 | $99.9 |
News
Fundamentals
| Market cap | $10.48B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 680.60M |
| Revenue | $6.82B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $309.60M |
| Revenue Q/Q | -0.34% |
| Revenue Y/Y | -3.12% |
| P/E ratio | 33.85 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.54 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $0.45 |
|---|---|
| ROA | 2.42% |
| ROE | N/A |
| Debt/Equity | 1.47 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.54 |
| Quick ratio | 1.06 |